Antigen-binding molecules specifically binding to GPRC5D and CD3 and their pharmaceutical uses

The present disclosure relates to antigen-binding molecules specifically binding to GPRC5D and CD3 and their pharmaceutical uses. Said antigen-binding molecules can be used to treat tumor-related diseases.

Saved in:
Bibliographic Details
Main Authors YING, HUA, TAO, WEI-KANG, SHI, JIN-PING, YECHAO, BAI-HUI, YANG, XIAO-YING, ZHU, MAN-MAN, JIN, XIN-SHENG
Format Patent
LanguageChinese
English
Published 01.01.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to antigen-binding molecules specifically binding to GPRC5D and CD3 and their pharmaceutical uses. Said antigen-binding molecules can be used to treat tumor-related diseases.
Bibliography:Application Number: TW202312109389